A Study of CS1001 in Combination With Donafenib in Subjects With Advanced Solid Tumors
Clinical trial NCT04472858 · UNKNOWN
Trial details
- NCT number
- NCT04472858
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-15
- Primary completion
- 2023-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.